Prosecution Insights
Last updated: April 19, 2026

Immunocore Limited

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18064180 Peptides XIAO, YAN 1642 Non-Final OA Dec 09, 2022
17998032 SOLUBLE TCRS AND FUSIONS TO ANTI-CD3 RECOGNIZING KRAS G12D FOR THE TREATMENT OF CANCER EDGINGTONGIORDANO, FRANCESCA 1643 Non-Final OA Nov 05, 2022
17929682 BIFUNCTIONAL POLYPEPTIDES SKELDING, ZACHARY S 1644 Non-Final OA Sep 02, 2022
17423843 FORMULATIONS VAN DRUFF, SYDNEY 1643 Non-Final OA Jul 16, 2021

Managing Immunocore Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month